A multicenter retrospective study, conducted in China from January 2009 to December 2022, identified 24 cases of SM with AML1::ETO+ AML across 16 centers and 212 cases of AML1::ETO+ AML with KIT mutations within the same timeframe (7). Here, RUNX1T1 is linked to systemic mastocytosis.